XML 45 R24.htm IDEA: XBRL DOCUMENT v3.23.1
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)
3 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Inventory
Components of selected captions in the consolidated condensed balance sheets consisted of the following:
March 31, 2023December 31, 2022
Inventories
Raw materials$164.6 $156.4 
Work in process206.4 177.4 
Finished products543.3 541.7 
$914.3 $875.5 
Schedule of Accrued and Other Liabilities
March 31, 2023December 31, 2022
Accrued and other liabilities 
Employee compensation and withholdings$225.8 $268.7 
Taxes payable120.8 50.6 
Property, payroll, and other taxes53.6 45.6 
Research and development accruals67.7 66.9 
Accrued rebates112.3 116.1 
Fair value of derivatives23.4 20.7 
Accrued marketing expenses13.2 17.0 
Legal and insurance29.1 28.1 
Intellectual property agreements (a)
95.4 53.3 
Accrued relocation costs26.2 25.2 
Accrued professional services10.6 6.6 
Accrued realignment reserves14.8 15.6 
Other accrued liabilities83.2 80.6 
$876.1 $795.0 
_______________________________________
(a)     As of March 31, 2023, $95.4 million was accrued in "Accrued and other liabilities" and $130.1 million was accrued in "Litigation agreement accrual" on the consolidated condensed balance sheet related to intellectual property agreements with Abbott Laboratories and its direct and indirect subsidiaries, and Medtronic, Inc.
Schedule of Supplemental Cash Flow Information
Supplemental Cash Flow Information
(in millions)
Three Months Ended
March 31,
20232022
Cash paid during the year for:
Amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases
$7.1 $7.6 
Non-cash investing and financing transactions:  
Right-of-use assets obtained in exchange for new lease liabilities$2.2 $6.4 
Capital expenditures accruals$26.5 $23.8 
Schedule of Cash and Cash Equivalents
Cash, Cash Equivalents, and Restricted Cash
(in millions)
March 31, 2023December 31, 2022
Cash and cash equivalents$872.5 $769.0 
Restricted cash included in other current assets0.6 0.5 
Restricted cash included in other assets3.3 3.1 
Total cash, cash equivalents, and restricted cash$876.4 $772.6 
Schedule of Restricted Cash
Cash, Cash Equivalents, and Restricted Cash
(in millions)
March 31, 2023December 31, 2022
Cash and cash equivalents$872.5 $769.0 
Restricted cash included in other current assets0.6 0.5 
Restricted cash included in other assets3.3 3.1 
Total cash, cash equivalents, and restricted cash$876.4 $772.6